Since PTEN has been reported as a potential therapeutic target in motor neuron diseases, including ALS or SMA (spinal muscular atrophy) [268,269,270], it remains possible that PTEN mRNA could also be part of ALS-linked ceRNETs. The gene discussed is PTEN; the disease is spinal muscular atrophy.